Who evaluates p16 immunohistochemistry?

APMIS. 2015 Oct;123(10):912-3. doi: 10.1111/apm.12421. Epub 2015 Jul 14.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Carcinoma, Squamous Cell / virology
  • Cyclin-Dependent Kinase Inhibitor p16
  • Human papillomavirus 16 / pathogenicity
  • Human papillomavirus 18 / pathogenicity
  • Humans
  • Immunohistochemistry
  • Neoplasm Proteins / metabolism
  • Oropharyngeal Neoplasms / virology*
  • Papillomavirus Infections / pathology
  • Papillomavirus Infections / virology

Substances

  • CDKN2A protein, human
  • Cyclin-Dependent Kinase Inhibitor p16
  • Neoplasm Proteins